It is with great satisfaction that we invite you all to participate in the conference SNOLA 2022 – Translational research to current and future treatments, which will take place on February 11th and 12th, 2022, 100% online. This will be the largest and most complete Neuro Oncology event in Latin America. Snola was born and remains focused on making accessible the content of knowledge and integration of all areas involved in oncological treatments of the of the Central Nervous System, therefore, we are committed to delivering the best of the best to Latin American specialists, as we always seek to do. Our last biannual congress had more than 1000 participants, 201 brazilian speakers, 76 international speakears and 7 sponsor. This success was achieved despite all the difficulties that this multidisciplinary area faces in scientific and practical terms. The world pandemic scenario made us change our plans, and the conference that would take place in 2020 in Buenos Aires had to be postponed. In view of the new reality, we proposed to hold the congress 100% online with scientific programming focused on what is new in our field, themes and studies that have shownpromise for new protocols, new approaches to the already known ones, as well

  Sign up for London Global Cancer Week 2021! Renowned international speakers will be discussing the impact of the Pandemic and the post-COVID-19 changes in the area of oncology in Latin America. The online event will take place on Friday, November 19th, 2 pm - 4 pm (GMT) - 10 am -12 am (BRT).  

Brazilian researchers are asking for funding for a study that is close to identifying the best course of preoperative treatment for breast cancer and which will have benefits for women around the world. The Projeto Cura Institute has launched a campaign for donations from the public: "Together we can be stronger than Cancer", which is aiming to raise enough funds to enable data to be processed for one year as part of a completely Brazilian-based piece of research into the sequences for the treatment of HER2-negative type breast cancer. The NeoSamba study is a randomized clinical trial, which is now in phase 3. It is examining a new sequence of treatment including neoadjuvant chemotherapy (before breast surgery) and intends to monitor the treatment of almost 500 women over three years. During ASCO, the conference of the American Society of Clinical Oncology, in 2018, Dr. José Bines, the principal investigator for the study, talked about the conclusion of Phase II of NeoSamba. The research was conducted by the National Cancer Institute (INCA) and it investigated the cases of 118 patients to assess whether changing the order of the drugs in the anthracyclines and taxane classes (some of the most commonly-used drugs for chemotherapy) would

Live Webinar, Saturday October 16th 10 renowned experts will discuss advances in the ESMO IN FOCUS LATAM 2021 Webinar and clinical challenges in Latin America. ESMO IN FOCUS is an Official ESMO program. The program will offer selected topics, including original presentations from the ESMO CONGRESS 2021. Renowned international speakers will select the most significant studies and comment on the main results with clinical impact. Relevant regional speakers will complement the presentation, demonstrating changes in clinical practice with updates to the treatment algorithm. Each section will feature a rich clinical discussion moderated by the program Chair and Co-Chair, complemented by questions from the participating audience. Register here to participate: https://www.esmoinfocuslatam2021.com Simultaneous translation: English/Spanish/Portuguese ESMO in Focus – Webinar LATAM 2021 is an officially licensed program of the European Society for Medical Oncology (ESMO), licensed exclusively by Springer Health do Brasil Ltda., sponsored by MSD in Latin America. © Copyright 2021 European Society for Medical Oncology. All rights reserved. This programme is made available in Latin America solely for educational and informational purposes and personal use only. Unauthorized reproduction is prohibited.

This event is intended to address concerns about women’s health, through an educational program, with debates between the best experts in the field. It aims to empower patients and managers in NGOs to be able to share information on the best practices for breast cancer treatment and also to help influence future government policy. Subscribe now: http://www.forumcura.com.br